功能纳米酶系统用于通过cuproptosis和ferroptosis激活协同瘤免疫疗法
Lina Gu1, Ying Sun2,3, Tingjie Bai2
1Department of Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, 150076, China.
Journal of nanobiotechnology
|March 16, 2025
概括
这项研究介绍了CussOMEp,这是一种新的纳米酶系统,通过诱导细胞死亡途径 (如cuproptosis和ferroptosis) 来增强癌症免疫疗法. 当与PD-1抗体相结合时,CussOMEp有效地向瘤,促进免疫反应和抑制转移.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 癌症免疫学 癌症免疫学
背景情况:
- 升高的铜诱导瘤缩和铁缩,触发免疫细胞死亡和抗瘤免疫力.
- 瘤细胞破坏铜代谢的调节,缺氧微环境限制了治疗效果.
研究的目的:
- 开发一种纳米酶系统 (CussOMEp),用于增强协同的瘤免疫疗法.
- 为了利用cuproptosis和ferroptosis改善癌症治疗.
主要方法:
- CussOMEp包括一个基于铜的PEGylated纳米导体 (CussNV) 装有梅,一个铜输送抑制剂.
- CussNV表现出过氧化酶,谷氨氧化酶和类似酶的活动,产生氧和基基.
- 奥梅普拉抑制ATP7A,增加细胞内铜和氧化应激.
主要成果:
- 通过耗尽谷氨,CussOMEp可以缓解瘤缺氧,并诱导铁亡.
- 它通过增强脂质化蛋白质寡合化来促进cuproptosis.
- 在乳腺瘤模型中,CussOMEp刺激了抗瘤免疫反应,与αPD-1一起,显著抑制了转移.
结论:
- CussOMEp是一种功能纳米酶系统,用于协同瘤免疫疗法.
- 它有效地结合了ferroptosis和cuproptosis诱导用于癌症治疗.
- 这一策略显示出克服治疗耐药性和改善治疗结果的前景.
更多相关视频
08:02Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
Published on: May 14, 2021
5.5K
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
16.6K
相关概念视频
01:27Tumor Immunotherapy
457
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
457
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K